A bedside score that could foretell heart surgery risks

NCT ID NCT07745283

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study asks whether a simple bedside score, called the Vasoactive Inotropic Score (VIS), can help predict which adults are at higher risk of complications after heart surgery using a heart-lung machine. The score is calculated from the doses of heart-support medications a patient is already receiving, so no extra tests are needed. Researchers will measure VIS at several points in the first two days after surgery in 617 adults undergoing procedures like valve repair or coronary bypass. The goal is to see if early VIS readings can flag patients more likely to experience serious issues such as kidney injury, stroke, or the need for extra circulatory support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this score proves reliable, it could help doctors identify high-risk heart surgery patients earlier and monitor them more closely, potentially reducing serious complications.
What could go wrong
This is an observational study, so it can show links but not prove cause and effect. The score's usefulness may vary across different hospitals and patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGICAL PROCEDURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sir Ganga Ram Hospital

    Delhi, National Capital Territory of Delhi, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.